טוען...

Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score

Background: Risk of substantial haemorrhage represents a critically important limitation to effective anti-thrombotic treatment in patients with atrial fibrillation (AF). While it is known that this risk is increased in anticoagulated patients either in the presence of anti-aggregatory drugs or conc...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Am J Cardiovasc Dis
Main Authors: Procter, Nathan EK, Ball, Jocasta, Heresztyn, Tamila, Nooney, Vivek B, Liu, Saifei, Chong, Cher-Rin, Ngo, Doan TM, Isenberg, Jeffrey S, Chirkov, Yuliy Y, Stewart, Simon, Horowitz, John D
פורמט: Artigo
שפה:Inglês
יצא לאור: e-Century Publishing Corporation 2015
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539096/
https://ncbi.nlm.nih.gov/pubmed/26309773
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!